Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model

Open access
Callegari, Elisa, Elamin, Bahaeldin K., Giannone, Ferdinando, Milazzo, Maddalena, Altavilla, Giuseppe, Fornari, Francesca, Giacomelli, Luciano, D'Abundo, Lucilla, Ferracin, Manuela, Bassi, Cristian, Zagatti, Barbara, Corrà, Fabio, Miotto, Elena, Lupini, Laura, Bolondi, Luigi, Gramantieri, Laura, Croce, Carlo M., Sabbioni, Silvia, Negrini, Massimo·2012·Hepatology

Abstract

MicroRNA-221 (miR-221) is one of the most frequently and consistently up-regulated microRNAs (miRNAs) in human cancer. It has been hypothesized that miR-221 may act as a tumor promoter. To demonstrate this, we developed a transgenic (TG) mouse model that exhibits an inappropriate overexpression of miR-221 in the liver. Immunoblotting and immunostaining confirmed a concomitant down-regulation of miR-221 target proteins. This TG model is characterized by the emergence of spontaneous nodular liver lesions in approximately 50% of male mice and by a strong acceleration of tumor development in 100% of mice treated with diethylnitrosamine. Similarly to human hepatocellular carcinoma, tumors are characterized by a further increase in miR-221 expression and a concomitant inhibition of its target protein-coding genes (i.e., cyclin-dependent kinase inhibitor [Cdkn]1b/p27, Cdkn1c/p57, and B-cell lymphoma 2–modifying factor). To validate the tumor-promoting effect of miR-221, we showed that in vivo delivery of anti-miR-221 oligonucleotides leads to a significant reduction of the number and size of tumor nodules. Conclusions : This study not only establishes that miR-221 can promote liver tumorigenicity, but it also establishes a valuable animal model to perform preclinical investigations for the use of anti-miRNA approaches aimed at liver cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.25747

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 170

Metadata

Authors
Callegari, E., Elamin, B. K., Giannone, F., Milazzo, M., Altavilla, G., Fornari, F., Giacomelli, L., D'Abundo, L., Ferracin, M., Bassi, C., Zagatti, B., Corrà, F., Miotto, E., Lupini, L., Bolondi, L., Gramantieri, L., Croce, C. M., Sabbioni, S., & Negrini, M.
Venue
Hepatology
Published
2012-09
Volume
56
Issue
3
Pages
1025-1033
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2170097870
Cited by
170
References
3
FWCI
5.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. https://app.cochat.ai/papers/10.1002/hep.25747
The paper
Callegari, E., Elamin, B. K., Giannone, F., Milazzo, M., Altavilla, G., Fornari, F., Giacomelli, L., D'Abundo, L., Ferracin, M., Bassi, C., Zagatti, B., Corrà, F., Miotto, E., Lupini, L., Bolondi, L., Gramantieri, L., Croce, C. M., Sabbioni, S., & Negrini, M. (2012). Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology. https://doi.org/10.1002/hep.25747

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.